Citations

Clear

8 citation(s) found for "Liu, David".

American Radium Society Appropriate Use Criteria for the use of liver‐directed therapies for nonsurgical management of liver metastases: Systematic review and guidelines
Hallemeier, Christopher L. , Sharma, Navesh , Anker, Christopher J. , Lee, Percy, Williams, Vonetta M. , Kennedy, Timothy J., Jethwa, Krishan R. , Kumar, Rachit , Russo, Suzanne , Jethwa, Krishan , Small, William , Hallemeier, Christopher Leigh , Selfridge, Jennifer Eva , Lee, Percy , Jabbour, Salma K , Liu, David M. , Kim, Ed, Tchelebi, Leila T. , Russo, Suzanne

Mayo Clinic

Cancer | July 6, 2023 | Volume: 129 | Issue: 20 | Pages: 3193-3212

10.1002/cncr.34931 | PMID 37409678 Get It

AbstractThe liver is a common site of cancer metastases. Systemic therapy is widely accepted as the standard treatment for liver metastases (LM), although select patients with liver oligometastases may be candidates for potentially curative liver resection. Recent data support the role of nonsurgical local therapies such as ablation, external beam radiotherapy, embolization, and hepatic artery infusion therapy for management of LM. Additionally, for patients with advanced, symptomatic LM, local therapies may provide palliative benefit. The American Radium Society gastrointestinal expert panel, including members representing radiation oncology, interventional radiology, surgical oncology, and medical oncology, performed a systemic review and developed Appropriate Use Criteria for the use of nonsurgical local therapies for LM. Preferred Reporting Items for Systematic reviews and Meta‐Analyses methodology was used. These studies were used to inform the expert panel, which then rated the appropriateness of various treatments in seven representative clinical scenarios through a well‐established consensus methodology (modified Delphi). A summary of recommendations is outlined to guide practitioners on the use of nonsurgical local therapies for patients with LM.
Deep‐learning based fast and accurate 3D CT deformable image registration in lung cancer
Ding, Yuzhen , Feng, Hongying , Yang, Yunze, Wong, William W. , Yu, Nathan Y. , Schild, Steven E. , Holmes, Jason , Liu, Zhengliang , Liu, David M. , Sio, Terence T. , Li, Baoxin , Liu, Wei

Mayo Clinic

Medical Physics | June 8, 2023 | Volume: 50 | Issue: 11 | Pages: 6864-6880

10.1002/mp.16548 | PMID 37289193 Get It

AbstractBackgroundDeformable Image Registration (DIR) is an essential technique required in many applications of radiation oncology. However, conventional DIR approaches typically take several minutes to register one pair of 3D CT images and the resulting deformable vector fields (DVFs) are only specific to the pair of images used, making it less appealing for clinical application.PurposeA deep‐learning‐based DIR method using CT images is proposed for lung cancer patients to address the common drawbacks of the conventional DIR approaches and in turn can accelerate the speed of related applications, such as contour propagation, dose deformation, adaptive radiotherapy (ART), etc.MethodsA deep neural network based on VoxelMorph was developed to generate DVFs using CT images collected from 114 lung cancer patients. Two models were trained with the weighted mean absolute error (wMAE) loss and structural similarity index matrix (SSIM) loss (optional) (i.e., the MAE model and the M+S model). In total, 192 pairs of initial CT (iCT) and verification CT (vCT) were included as a training dataset and the other independent 10 pairs of CTs were included as a testing dataset. The vCTs usually were taken 2 weeks after the iCTs. The synthetic CTs (sCTs) were generated by warping the vCTs according to the DVFs generated by the pre‐trained model. The image quality of the synthetic CTs was evaluated by measuring the similarity between the iCTs and the sCTs generated by the proposed methods and the conventional DIR approaches, respectively. Per‐voxel absolute CT‐number‐difference volume histogram (CDVH) and MAE were used as the evaluation metrics. The time to generate the sCTs was also recorded and compared quantitatively. Contours were propagated using the derived DVFs and evaluated with SSIM. Forward dose calculations were done on the sCTs and the corresponding iCTs. Dose volume histograms (DVHs) were generated based on dose distributions on both iCTs and sCTs generated by two models, respectively. The clinically relevant DVH indices were derived for comparison. The resulted dose distributions were also compared using 3D Gamma analysis with thresholds of 3 mm/3%/10% and 2 mm/2%/10%, respectively.ResultsThe two models (wMAE and M+S) achieved a speed of 263.7±163 / 265.8±190 ms and a MAE of 13.15±3.8 / 17.52±5.8 HU for the testing dataset, respectively. The average SSIM scores of 0.987±0.006 and 0.988±0.004 were achieved by the two proposed models, respectively. For both models, CDVH of a typical patient showed that less than 5% of the voxels had a per‐voxel absolute CT‐number‐difference larger than 55 HU. The dose distribution calculated based on a typical sCT showed differences of ≤2cGy[RBE] for clinical target volume (CTV) D95 and D5, within ±0.06% for total lung V5, ≤1.5cGy[RBE] for heart and esophagus Dmean, and ≤6cGy[RBE] for cord Dmax compared to the dose distribution calculated based on the iCT. The good average 3D Gamma passing rates (> 96% for 3 mm/3%/10% and > 94% for 2 mm/2%/10%, respectively) were also observed.ConclusionA deep neural network‐based DIR approach was proposed and has been shown to be reasonably accurate and efficient to register the initial CTs and verification CTs in lung cancer.
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients
Deeb, G. Michael , Grube, Eberhard, Windecker, Stephan , Gada, Hemal, Mumtaz, Mubashir , Heiser, John, Merhi, William , Kleiman, Neal S. , Chetcuti, Stanley, Gleason, Thomas G. , Lee, Joon Sup, Cheng, Wen , Makkar, Raj , George, Barry, Kodali, Susheel , Yakubov, Steven J. , Lange, Rüdiger , Piazza, Nicolò , Oh, Jae K. , Li, Shuzhen , Reardon, Michael J. , Investigators, SURTAVI Trial, Gitter, Christopher B., Roberts, Dana, Bae, Richard , Sorajja, Paul , Sun, Benjamin , Askew, Judah, Eales, Frazier, Goessl, Mario, Kshettry, Vibhu R., Pedersen, Wesley R., Poulose, Anil, Roohani, Pezhman, Farivar, Robert Saeid, Shronts, Richard, Tarrel, R, Young, Mark , Butkus, Eddy, Pendleton, Kristin, Fry, Robert D., Heine, Carl, Roe, Kristin La, Weig, Laura, Agarwal, Himanshu , Langdon, Thomas, Satpathy, Ruby, Batter, John, Bremer, Karen, Indukuri, Unajyothi, Baas, Marijke, Oomes-Sistermans, Corry, Smits, Manola, Coenen, Carien, Driesen, Inge, Lauryssen, Lia, Poorter, Margreet, Schaap, Jeroen , Bentala, Mohamed, Heijer, Peter den, Remmers, Michel, Story, Marie, Erven, Paul M.M. van, Verbiest, H, Vos, Jeroen, Bennett, Michelle , Dunaj, Wendy, Seaton, Deborah, Waller, Deborah A., Khandheria, Bijoy K. , Bajwa, Tanvir , O’Hair, Daniel, Gheith, Ayman, Marriott, Elizabeth , Qhavi, Ajaz, Saxena, Varun Kumar, Shhadeh, Akram, Yeomans, Christine, Bessette, Lynn, Byrne, Jessica, Kieckhefer, Heather, Munoz, Marleny, Russo, Elizabeth, Morgan, Michael M., Byrne, Timothy , Caskey, Michael, Amabile, Orazio , Brady, Kevin P., Chung, Steven, Dacanay, Kelly, Fang, Hao , Franz, Douglas , Kelly, Claire , Loli, Akil , Payne, Jeremy, Wang, Norman C. , Lott, Jessi, Pool-Owens, C. Angele, Porter, Charlotte M., Hennan, Jeffrey A., Garrett, H. Edward , Paulus, Basil, Craig, J. Cymerman, Samaha, Joseph, Wolf, Bradley A., Wright, Lance, Zoghbi, Gilbert J., Willcott, Leslie, Roberts, Brad, Hebeler, Robert F., Stoler, Robert , Graybeal, Dion, Grayburn, Paul , Henry, Carl Ferdinand Howard, Mir, Osman , Vallabhan, Ravi C. , Fanous, Matthew , Kaufman, Jenifer, Chang, James D. , Manning, Warren J. , Riley, Marilyn F., Khabbaz, Kamal R. , Popma, Jeffrey J. , Caplan, Louis R. , Chui, Shing Fung, Guibone, Kim, Kumar, S. Sendil , Lioutas, Vasileios‐Arsenios , Nathan, Senthil , Searls, D. Eric, Fisher, Susan G. , Guirgues, Lindsay, Henderson, Sue, Loving, Laura Ashley, McWalters, Nicole, Patterson, Kelly, Burkart, Jesse, Carcedo, Bryan, Stacey, Russell, Bladergroen, Mark, Edmonson, Supakunya, Epps, Stacey, Katz, Marc , Sangha, Amandeep, Aucoin, Jennifer, Roberts, Monique, Aubin, Jaime, Hotard, Callie, Tassin, Michelle, Fail, Peter , Feinberg, Edgar, Netherland, Donald, Abben, Richard, Allam, Mohamad, Bates, Michael , Dearman, Richard, Gervais, Donald, Haight, Edward, Metes, Michael, Naquin, Jeanette, Tedesco, Victor, Thibodeaux, Lisa, Thompson, Karen , Aberle, Sally, Amaro, Dana, Rose, Geoffrey, Schérer, M. , Rinaldi, Michael , Skipper, Eric, Bridges, Charles R., Downey, William, Iyengar, Phaniraj, Martin, Jerry L., Ryan, Liam , Stiegel, Robert M., Story, John S., Alsabaawi, Khaled, Gheorghiu, Mitch, Singh, Chetana, Yashar, Jason, Siegel, Robert J. , Cheng, Wen, Altman, Karen, Jilaihawi, Hasan , Khouw, Stephanie, Salseth, Tracey, Stegic, Jasminka, Trento, Alfredo , Lazarte, Rosa, Sohn, Jeanie, Khalique, Omar , Castellon, Marco Gonzalez, Contreras, Jose Gutierrez, Kitago, Tomoko , Lekic, Tim, Naka, Yoshifumi , Smith, Craig R. , Abreu, Leana, Clement, Emerson, Sabir, Sajjad, Aji, Janah, Bowen, Frank W., Kaddissi, Georges, Mirsen, Thomas, Muntazar, Muhammad, Ogbara, Jeffrey, Rosenbloom, Michael , Schell, W, Then, Ryna , Carl, Heidi, Kreydi, Ghassan, Wolak, Heather, Sandidge, Gregory, Ali, Omar, Asfaw, Zewditu E., Kafi, Ali, Schreiber, Theodore , Andaya, Lourdes, Baciewicz, Frank A., Bassett, Joseph, Choksi, Nishit, Kassas, Safwan, Munir, Ahmad, Kothmeier, Franziska, Stroh, Annemarie, Goppel, Gertrud, Hettich, I, Opitz, A, Ruge, Hendrik , Badiu, Cătălin Constantin , Brenner, Susanne C. , Ehlmidi, Yacine, Herold, Ulf, Kreuzpointner, Robert Josef, Mazzitelli, Domenico, Vincze, Dóra, Camuglia, Krista, Cowhig, Dahlia, Newbold, Stephanie P. , Pierce, Cynthia, Wootton, Samantha, Vemulapalli, Sreekanth , Babi, Ali, Banks, Adam, Gaca, Jeffrey G., Glower, Donald D. , Halim, Sharif, Hendry, Robert, Hernández, Christian , Kiefer, Todd L., Marrotte, Eric J. , Maldonado, Andres Pineda, Wyck, David Van , Vavalle, John P. , Vora, Amit N. , Zeylikman, Yuriy, Amber, Kara, Barnitt, Anne, Lamm, Janet E., Mandelstam, Lara, Schroeder, Ryan W. , Sumner, Roxanne, Nair, Deepu, De, Ajanta, Gaudiani, Vincent A., Joye, James D., Brown, Lidia, Hessler, Christine, Rammohan, Chad, Vial, Conrad, Charles, Elizabeth S. , DeQuesada, Angela, Kaner, Maria, Mathewson, Sonya, Pitts, Kristy, Wheeler, Lauren , Wilson, Ashley, Davidson, Estella, Frohwein, Stephen, Lerakis, Stamatios , Sullivan, Angela, Babaliaros, Vasilis , Guyton, Robert A. , Thourani, Vinod H. , Anderson, Aaron, Belagaje, Samir , Benameur, Karima , Devireddy, Chandan , Harrison, A , Hudson, Kristen, Lieppe, William, Macheers, Steven, Mavromatis, Kreton , Sanders, Keith A., Sarin, Eric L., Winkel, Daniel, Duininck, Liesbeth W., Gussinklo, Titia, Jadoenath-Oedai, Shashikala, Ruiter, Arno, Berg, Nico van den, Velden-Macauley, Liz E.N. van der, Huis, Maaike van, Verelst, S., Geleijnse, Marcel L. , Vletter, Wim B., Bekker, Margaretha, Bekkers, Joseph A., Biesheuvel, Karla, Birim, Özcan, Raap, Goris Bol, Daemen, Joost , Jaegere, Peter Paul de, Wijngaarden, Rob de Lind van, Khajeh, Ladbon, Kik, Charles, Oei, Frans B S , Scheele, Maaike, Woestijne, Pieter C. van de , Geuns, Robert‐Jan van , Leeuwen, Wouter J. van, Henderson, Amy, Straight, Faye, Tischler, Marc E., Dauerman, Harold L. , Ittleman, Frank, Schmoker, Joseph, Abernethy, Abraham, Alkhalil, Imran, Azarbal, Amir , Chava, Sreedivya, Commichau, Christopher, Denkmann, Jan, DeStephan, Christine M., Ehle, Gregory, Falduto, Catherine, Gorman, Mark , Kadavath, Sabeeda , Leavitt, Bruce J., Mack, Allison, Malasana, Gangadhar, Moossavi, Shahab, Phuong, Newton , Rambod, Mehdi, Sharma, Ashwini , Terrien, Edward F., Worgan, Barbara, Zeglin-Sawczuk, Magdalena, Burgess, Brian , Killbride, Susan, Temple, Amy, Burnside, Joyce, Good, Christopher, Agarwal, Shikhar , Casale, Alfred S., Skelding, Kimberly A., Carter, Russell, Cummings, Christopher L. , Grana, Vicente, Haegerl, Carl, Harjai, Kishore J. , Singh, Deepak , Stahl, Russell F., Stella, Joseph, Stewart, Birute, Wood, Kim, Alexander, Donna, Barton, S. G., Logtens, Elaine, Marsh, Anna-Marie , McAdam, John, Kovac, Jan , Spyt, Tomasz, Garimella, Soumitra, Szostek, J., Zlocha, Viktor, Kirkland, Lavonda, Reid, Lori L., Reilly, Susan, Menderhall, Melody, Martin, William, Park, Steven , Smith, J. Michael, Gersch, Karen, Hiratzka, Loren F. , Kachoris, John, Okum, Eric , Cardozo, Maria , Cyr, G., Duvall, W. Lane , Flynn, Aidan , Krupowies, Nancy, Parker, Matthew , Hagberg, Robert, McKay, Raymond G. , Azemi, Talhat, Brown, Robert S., Fusco, Daniel, Hosley, Catherine, Kiernan, Francis J., Margey, Ronan, Preissler, Paul, Sadiq, Immad R., Silverman, Isaac, Taboada, Susan, Underhill, David J, Lopez, Becky, Mullin, Stephanie, Quesada, Christine, Lawrence, Tracy , Naqvi, Tasneem Z. , Matthews, Ray , Starnes, Vaughn A., Clavijo, Leonardo , Cunningham, Mark J. , Kim‐Tenser, May , Sanossian, Nerses , Shavelle, David M. , DelMotte, Danielle, Henry, Samantha, Moltrassie, JoAnne, Cooper, Raymond, Lee, James T. , Parikh, Sachin , Zweig, Brian, O’Neill, William, Paone, Gaetano , Borgi, Jamil, Brewer, Robert J., Eng, Marvin H. , Miller, D. Claire , Mitsias, Panayiotis , Morgan, Jeffrey A. , Nemeh, Hassan, Muñoz, Javier Alcaide, Fernandez, Maria Medina, Chinchilla, Fernando Carrasco, Bailón, Isabel Rodríguez, Garcı́a, José Marı́a Hernández, Such, Miguel, Alonso‐Briales, Juan H., Cosme, Carlos de la Cruz , Domínguez-Franco, Antonio J., López, Maria J. Mataró, Melero, José M., Muñoz-Garcia, Antonio-Jesus, Espín, Gemma Sánchez, Maese, Jose Manuel Fernández, Suarez, Esther Villa, Hera, Jesús M. de la, Cortina, Juan Carlos Llosa, Tassa, Cesar Morís de la, Fernández, Pablo Avanzas, Fernández, Lorena Benavente, Calleja, S. , Valle, Raquel Del, Pérez, Carlos Morales, Silva, Jacobo , Bluntschli, Eva, Keller, Dorothée, Maritz, Sandra, Ruest, Rafael, Schönenberger, Christa, Trovato, Moreno, Brugger, Nicolas , Göber, Volkhard, Kurmann, Reto , Reineke, Sylvia, Zürcher, Fabian, Carrel, Thierry , Balasubramaniam, Rupashani, Bellwald, Sebastian, Broeg, Anne, Bühlmann, Monika , Büllesfeld, Lutz, Chaloulos-Lakovidis, Panagiotis, Englberger, Lars, Gloekler, Steffen , Goldlin, Martina Beatrice, Huber, Christoph , Khattab, Ahmed A., Kurmann, Rebekka , Liesirova, Kai , Maamari, Basel , Mattle, Heinrich P. , Meinel, Thomas R. , Panos, Leonidas D , Schönhoff, Florian, Sleszak, Agnieszka, Vaisnora, Lukas , Martial, Rascha von, Wenaweser, Peter, Zuk, Katarzyna, Musso, Iris, Allen, Meredith, Gonzales, Michael , Horton, Ken, Doty, John R., Caine, W. , Clayson, Stephen E., Harkness, James, Hoesch, Robert, Huan, Mengjing, Jones, K., Miner, Edward, Reid, B.B., Sunderman, Elizabeth, Citro, Kathleen, Fisher, Michele, Willhide, Judi, Corretti, Mary C., Conte, John V., Mandal, Kaushik , Resar, Jon R. , Chacko, Matthews, Hasan, Rani K. , Heil, Barbara, Marsh, Elizabeth, Price, Joel , Sciortino, Chris, Tolentino, Jennie, Bui, Anh, Lee, Ming Sum, Watanabe, Colin, Aharonian, Vicken, Moore, Naing, Ajani, Zahra , Mansukhani, Prakash, Sangha, Navdeep , Yun, Kwok L., Hylander, Susanne, Corbascio, Matthias , Hillebrant, Carl-Gustaf, Feldt, Kari , Kostulas, Konstantinos, Settergren, Magnus , Yamasaki, Keita, Anderson, Michelle A. , Bloomfield, Charlotte E., Burton-Wood, Natalie, Harland, Charlotte, Somers, Kathryn, Ware, Tracey L., Deakin, Sarah, Geldard, Susan, Schlosshan, Dominik , Blackman, Daniel J. , Kaul, Pankaj , Evans, Betsy, Javangula, Kalyana, Limaye, Sameer S., Malkin, Christopher J. , Wanklyn, Peter, Farhi, Anita, Manapat, Arika, Maranan, Leandro, Mihelis, Effe, Ng, Amelia, Ricketts, Melissa L., Kronzon, Itzhak, Perk, Gila, Brinster, Derek R., Kliger, Chad , Azhar, Salman , Bonomo, Roger, Dharva, Rubin, Fontana, Gregory P., Mandel, Steven, Mehla, Priti , Patel, Nirav , Plestis, Konstadinos A. , Fox, Stephanie A. , Mardell, Stephen, Novick, Teresa, Sandie, Kelsey, Jonge, Wes de, McLeod, Claudia, Mroz, Luke, Weigand, Andrea, Kiaii, Bob, Teefy, Patrick, Debicki, Derek , Diamantouros, Pantelis , Mandzia, Jennifer , McKenzie, Francine, Valdis, Matthew , Young, Bryan D. , Klein, W, Sawicki, Kristina, Bakhos, Mamdouh, Leya, Ferdinand, Biller, José , Lewis, Bruce, Morales‐Vidal, Sarkis, Schneck, Michael, Tuchek, J. Michael, Biddle, Amanda, Ernst, Dereen, Haubenschild, Julie, Howe-Clayton, Desirae, Johnson, Ramona , Mundt, Pamela, Reiter, Jacqulyn, Kutzke, Kim, Maalouf, Joseph F., Sinak, Lawrence J., Pochettino, Alberto , Sandhu, Gurpreet S. , Alkhouli, Mohamad , Best, Patricia J.M. , Bresnahan, John F., Eleid, Mackram F. , Fulgham, Jimmy R., Greason, Kevin L. , Gulati, Rajiv , Holmes, David R. , Mathew, Verghese, Meissner, Irene, Radford, Jonathan, Reeder, Guy S., Sarraf, Mohammad , Suri, Rakesh M. , Swenson, Courtney, Williams, Lindsy N., Jiang, Zuyi, Lapierre, Serge, Phan, Thi Mong Ngoc, Buithieu, Jean, Varennes, Benoît de , Piazza, Nicolo, Lachapelle, Kevin , Liam, Durcan, Martucci, Giuseppe , Blömer, Han, Herder, Wiebren, Geest, Els Van der, Wal, Metske van der, Izaksson, Rob, Kootstra, Hetty, Pultrum, Maarten, Walinga, Tamara, Boonstra, Piet W. , Boven, Adrianus J. van, Amrane, Hafid, Hofma, Sjoerd H., Schuiling, Wouter J. , Terluin, Hanny, Timmerman, Margje, Weerdt, Arno Peter van der, Vossenberg, Tessel , Barnes, Caroline , Griffin, Sandra, Marcus, Rachel , Wang, Zuyue, Widell, Jared, Bafi, Ammar S., Waksman, Ron , Choi, Joseph , Corso, Paul J., Laureno, Robert, Lin, Mark, Lowery, Robert G. , Malla, Prerna , Pichard, Augusto D., Satler, Lowell F. , Shults, Christian, Decklever, Cecily, Evans, Danika, Tuttle, Kendra, Marcus, Richard H., Chawla, Atul, Hockmuth, David, Jacoby, Michael, Jenson, Bart, McAllister, David W., Prabhakar, Ganga, Verhofste, Marnix, Morin, Colette, Potvin, Lucie, Jean, Nathalie St., Garceau, Patrick, Asgar, Anita , Cartier, Raymond , Bonan, Raoul, Dominquez, Manuel, Dorval, Jean‐François , Ibrahim, Réda , Lavoie, Marc-André, Benner, Autumn, Brunetti, Deborah, Ciprich, Christine, Lobur, Elena, Lonergan, Noele, McGlew, Suellyn, Oplinger, Jeanne, Oster, Tracy, Polise, Lucille, Purpura, Jenelle, Sentman, Susan, Zile, Catherine Van, Arogundade, Olasunkanmi, Gillan, Linda, Koulogiannis, Konstantinos , Brown, John , Kipperman, Robert, Blitz, Lawrence R., Cohen, Barry M., Généreux, Philippe , Magovern, Christopher J., Rosenberg, Richard, Safirstein, Jordan, Turner, Joanne , Xydas, Steve, Jones, Teresa, Montgomery, Susan, Kovach, Todd, Navas, Jorge A. , Lin, Lang, Rovin, Joshua D. , Arora, Ajay , Ofenloch, John C., Schneider, Jean-Raphael, Spriggs, Douglas, Stone, Lisa Cacari , Turner, Nancy J. , Basnet, Sandeep , Bhat, Arjun, Fusilero, Michael, Muthiki, Sowmya, Muthyala, Samatha, Vrestil, Nicole Saint, Sharma, Madhav , Singh, Julie , Chaudhry, Farooq A. , Sengupta, Partho P. , Sharma, Samin K. , Tang, Gilbert H.L. , Anyanwu, Anelechi, Bronster, David J., Dangas, George , Kini, Annapoorna , Stelzer, Paul, Stewart, Allan, Swain, Julie A., Annunziato, Samantha, Delliliune, Diane, Garzon, Ruby, Seeratan, Vidya, Rosman, David A., Suma, Valentin, Trost, Biana, Hartman, Alan, Katz, Stanley, Rutkin, Bruce, Boutis, Loukas, Carey, Ruthanne, DeAngelis, Teresa, DeOrchis, Vincent, Esposito, Rick, Jauhar, Rajiv , Kaplan, Barry B., Laighold, Saaron, Meraj, Perwaiz , Palazzo, Robert E., Parihar, Raminder, Podwall, David, Yu, Pey‐Jen , Abu, Miriam, Bavbekova, Saniye, Bowden, Morgan, Clark, Emily, Gaudio, Stephanie, Houanche, Pascale, Kalish, Chloe, Kapitman, Anna, Lee, Hanah, Oviedo, F. Franch, Pushkar, Illya, Robin, Tonya, Shaheen, Devin, Sin, Danielle, Taylor, Zachary , Tovar, Joseph, Daele, Jessie Van, Vidal, Samantha, Yung, Lau Yan, Jilaihawi, Hasanian, Fara, Michael , Ischida, Koto, Loulmet, Didier F., Siller, K, Staniloae, Cezar , Torres, José, Zhang, Cen , Hartlev, Christie, Huffman, Andrew, Kellum, Annie, Liptrot, Roderick, Ryan, James , Lilly, Scott , Rushing, Gregory , Grose, Noah, Lee, Vivien , Mazzaferri, Ernest L. , Mutgi, Smil, O’Neil, Susan, Perchuk, Alex, Sai‐Sudhakar, Chittoor, Slivka, Andrew , Hanes, Stacie, Banowetz, Michael, Dautenhahn, David, Mehl, Brad, Bodenhamer, Robert Mark, Ghani, Mohammad , Raikar, Goya V., Tahirkheli, Naeem , Wasemiller, Wayne, Amoroso, Elisa M , Holt, Shelley, Tucker, Claire , Martin, Randolph P., Kauten, James, Rajagopal, Vivek , Awad, Eric, Brown, W. Morris, Gott, J. Richard, Karmpaliotis, Dimitrios, Meduri, Christopher, Polsani, Venkateshwar , Rinehart, Sarah, Seiden, Lawrence, Serbanescu, Andrei, Butler, Kim D. , Elsessor, Kayla, Fehr, Brittany, Hancock, Anthony, Hollister, Regina, MacFarlane, Dawn, Rodgers, Courtney, Todd, Anita, Eubanks, Veronica, Spangler, Jessica, Wirt, Katie, Wonders, Brook, Bachinsky, William , Maini, Brijeshwar , Mumtaz, Mubashir, Aneja, Parul, Loran, David B., Shah, Jagdish, Gebhardt, Linda L., Jones, U. V., Lauterborn, Marjo, John, Henriette , Parthier, Sonja, Schaprian, Katja, Twelker, K., Nickenig, Georg, Welz, Armin, Bode, Felix J. , Fuchs, Ângela, Mellert, F, Petzold, Gabor C. , Sedaghat, Alex, Sinning, Jan‐Malte, Werner, Nikos , Bang, Helle, Brodersen, Bente Birgitte, Christensen, Pernille Roed, Eriksen, Elsebet, Groth, Susanne , Larsen, Mie Christa Jensen, Johansen, Mette Ellegaard, Lilleør, Thomas Nikolaj Bang, Larsen, Lisette Lund, Preis, Anne-Cathrine, Rieck-Broberg, Jeanette, Ihlemann, Nikolaj , Noerager, Betina, Steinbrüchel, Daniel A., Arendrup, Henrik, Franzen, Olaf, Hansen, Klaus, Højgaard, Joan , Holme, Susanne, Kjøeller, Morten, Lund, J. O., Perko, Mario J. , Sander, Kåre, Smerup, Morten , Thiis, Jens J., Thyregod, Hans Gustav Hørsted , Monnin, Kathryn, Popelas, Lori, Slyman, Martha, Grewal, Kanny, Matros, Todd, Watson, Daniel, Arshi, Arash, Blossom, Geoffrey B., Chapekis, Anthony T., Duff, Steven B., Hicks, William, Holland, Stephanie , Kander, Nathan H., Lyons, Jefferson M., Mejilla, Jennifer, Reese, Brenda, Sanchez, Carlos E. , Vora, Nirav , Erwin, Sheila, Hall, Jamie , Hayes, Natalie, Miller, Margie, Main, Michael L., Allen, Keith B. , Aggarwal, Sanjeev, Borkon, Michael, Boutwell, Christine, Davis, James R. , Grantham, Aaron, Magalski, Anthony, Olds, Karin, Buchanan, Tiffany, Daniel, Misty, Estrada, Katrina, Hollen, Matthew, Lazarsfeld-Jensen, Ann , Kennen, Jada, Bechis, Mary, Rubenson, David, Teirstein, Paul, Ahmad, Daniel, Atri, Prashant , Azarbal, Farnaz, Brewster, Scot, Brown, Christopher , Foley, T. Raymond , Groves, Elliott M. , Kalafut, Mary, Levisman, Jeffrey, Mellinger, Douglas, Odunukan, Olufunso W. , Ong, Daniel, Oyama, Jared, Panguluri, Praveen, Raney, Aidan A., Rao, Suraj, Schultz, Jason, Sharma, Alok , Stinis, Curtiss, Thompson, C. Bradley , Wadia, Subeer , Walsh, Joseph, White, Jeremy , Purrington, Elizabeth, Zulick, Chelle, Murillo, Jaime , Mahoney, Paul, Newton, Joseph, Rich, Jeffrey, Bagameri, Gabor, Dimeling, George, Jordan, Grace, Mistry, Neville F., Philpott, Jonathan M. , Sirak, John, Sourbeer, Sarah, Talreja, Deepak, Zweifler, Richard M., Helm, Elizabeth, Postema, Karen, Over, Elizabeth Van, Chilton, Dale, Mitchell, Lou, Berkompas, Duane , Fanning, Justin, Khan, Muhib , Sang, Stephane Leung Wai , Omran, Kaskar, Patzelt, Lawrence H., Thoits, Timothy , Vijayappa, Madhu, Kasle, Margie, Trautman, Leigh, Dash, Rajiv, Fischbein, Michael P. , Fearon, William F. , George, Paul V., Speight, Martina K., Tai, Waimai Amy, Albersen, Inke, Bras, Rebecca Gornelda, Feirabend, Conny, Helwig-Vernooij, Johanna Catharina, Kranen, Gerda, Oostveen, Manfred, Rost, Ilona, Deutekom, Inge van, Weelden, Atie van, Heijmen, Robin, Bosschaert, Mike Arnoud Ramon, Kroon, Thomas L. de, Hilkens, P.H.E. , Mast, Eliza G., Rensing, B. J. W. M., Schonewille, W.J., Akker, Alberta Nelina van den, Haag, Elizabeth, Jennings, Joan, Krug, Patricia, Santiago, Lyn, Seth, Sonika , Dimsuyu, Nellia, Mihalatos, Dennis, Petrossian, George , Robinson, N. Bryce , Bercow, Neil, Berke, Andrew E. , Deutsch, Ezra, Stevens, Perry, Brown, Sue, Jardim, Victor Dos Santos, Radford, Nicole, Sookhoo, Venessa, Kyereme, Kojo, Punzalan, Rachel, Sculeany, Bogdan, Brecker, Stephen , Jahangiri, Marjan , Alassa, Aiman, Chandrasekaran, Venkatachalam, Clarke, Brian , Dowling, Cameron , Moynihan, Barry, Roy, David, Sarsam, Mazin A.I., Bess, Renee, Henkel, Megan, Cohen, Gerald M., Davis, Thomas, Aboukasm, Amer, LaLonde, Thomas , Yamasaki, Hiroshi , Burkert, Marylynn, Kingma, Barbara, Wheatley, Jessica, Segar, Douglas S., Heimansohn, David, Hermiller, James, Ball, Michael, Elsner, Gregory, Hanan, Scott A., Moainie, Sina L. , Nukes, Theodore, Reibold, Patrick, Robison, Robert, Salerno, Christopher T. , Sampson, Andrew, Walts, Peter A., Wandel, Emily, Li, Mary , Sarker, Sulagna, Ahmed, Shaheeda, Radhakrishnan, Sam, Arbel, Yaron , Christakis, George T., Cohen, Gideon, Czarnecki, Andrew , Hopyan, Julia, Komatsu, Ikki , McCraig, Kathleen, Shuvy, Menashe, Toma, Jonathan, Vincenzo, Basile, Wheeler, Cindi, Wolff, Rafael , Beck, Pamela J., Cabral, Donna J., DaCosta, Christine, Hudson, Laura, Pastie, Michelle, Abrahams, Nicole, Altamar, Ingrid, Buitrago, Mike, Cassman, Gabrielle, Leibovici, Zvi, Nelson, Ana, Recchia, Kelly, Robbins, Gillian, Studor, Kelly, Bethea, Brian, Beyer, Erik, Evans, Sharron, Goodis, Caleene, Mueller‐Kronast, Nils , Pantoja, Claudia, Wells, Channing, Youngblood, Colten, Snelus, Patricia, Gopal, Deepika, Jackson, Kristie, Brown, David L. , Ryan, William H. , Gopal, Ambarish, Harrington, Katherine, Mack, Michael J. , Nosnik, Pedro, Potluri, Srinivasa , Smith, Robert L. , Szerlip, Molly, Blaylock, Candice, Brinegar, Patricia, Canter, Laura, Green, LaShawna, Green, Lisa , Hazen, Pamela, Jacobs, Amber, Khan, Saba , Ludwig, Sheryl, Mata, Mary, Moore, Tammara, Underwood, Carol , Little, Stephen H. , Nagueh, Sherif F. , Albright, Kimberly, Barker, Colin M. , Bledsoe, Donald, Chiu, David, Gray, Tiffany , Imperial-Aubin, Delmar, Lin, Chun C., Moye, Stacy, Ramchandani, Mahesh, Ramlawi, Basel , Reul, Ross M. , Reyes, Manuel, Scheinin, Scott , Volpi, John , Ballmoos, Moritz Wyler von, Blackburn, Beth, Hart, Chari Y. T., Whitacker, Pearl, Lau, Jeffrey, Spies, Christian , Badawi, Ramy A., Graner, Sarah, Nakamura, Dean, Plank, Benjamin, Salem, Rony, Seto, Todd B. , Valenta, Douglas, Cruz, Amber, Gallagher, Lauren T. , Schuck, Laura, Weeks, Andre, Fishman, Lise, Schwarz, Teresa, Bavaria, Joseph E. , Anwaruddin, Saif , Giri, Jay , Khella, Sami, Li, Robert, McGarvery, Michael, Price, R A, Szeto, Wilson Y. , Sun, Yang , Wu, Libo , Tsang, Wendy , Thavendiranathan, Dinesh, Feindel, Chris, Casaubon, Leanne K. , Cusimano, Robert J. , Campo, Martín del , Osten, Mark , Höwisch-Pengel, Rita, Lechner, Gabriele, Steiger, Barbara, Allgeier, Martin, Jander, Nikolaus , Büttner, Heinz Joachim, Comberg, Thomas, Diab, Nawras , Gick, Michael, Günkel, Ludwig, Pingpoh, Clarence , Rothe, H. Jürgen, Thoma, Martin , Winker, Thomas, Häger, Christine , Sänger, Ulrike, Stader, Michael, Biaggi, Patric , Gruner, Christiane, Binder, Ronald K. , Corti, Roberto , Holy, Erik W. , Grünenfelder, Jürg , Maier, Willibald, Nietlispach, Fabian, Atkinson, Rachel , Davis, Angela , Hall, Suzanne, Mangene, Samantha, Mazzurco, Stacey, Hoit, Brian D. , Musarra, Raymond, Markowitz, Alan , Asi, Khaled, Attizzani, Guilherme F. , Chuang, Dennis Y. , Elgudin, Yakov , Le, Scott T., Serkin, Zakhar, Shams, Tanzila, Sila, Cathy, Simon, Daniel I. , Bezerra, Hiram G. , Greening, Kyle, Karson, Jodi, Page, Susie, Shawgo, Tilitha, Freeman, Jon C., Mulhern, Kevin, Nath, Jayant , Tadros, Peter, Zorn, George L., Hockstad, Eric, Lechtenberg, Colleen, Muehlebach, Gregory, Rippee, Michael , Rosterman, Lee , Sundararajan, Jayashree, Wang, Yunxia , Wiley, Mark, Atapattu, Suresh, Kall, Christian Marin y, Lowery, Maureen H., Marchena, Eduardo de , Salerno, Tomás A. , Carillo, Roger, Ferreira, Alexandre , Williams, Donald, Bhatt, Shradha, Migda, Erin M., Oakley, Jessica, Warshal, Wendy, Wilcock, Sandra, Booher, Anna M., LaBounty, Troy , Boyle, Mary Jo, Geml, Rachel, Grossman, Paul , Guerin, Danielle, Hodges, Kelley, Lammers, Deborah, Menees, Daniel, Patel, Himanshu J. , Prager, Richard L. , Romano, Matthew, Stamper, Angela, Wang, Michael, Ziarkiewicz, Melanie, Charlebois, Cheryl, Chilton, Colleen, Labinaz, Marino , Lam, Khanh, Masters, Roy G., Steffenhagen, Nikolai, Enlow-Germovsek, Melissa, Konopka, Kristin, McGargle, Rachel, Travis, Melissa, Anderson, Kathy, Crock, Fred, Edelman, Kathy, Katz, William E. , Aghaebrahim, Amin Nima, Al-Bayai, Alhamza, Bonaccorsi, Christina, Gulati, Deepak , Henry, Lisa, Kenmuir, Cynthia L. , Klein, Bradley G., Kliner, Dustin , Limaye, Kaustubh , Nanduri, Sunanda, Navid, Forozan, Patel, Pratit , Rocha, Marcelo Borges , Schindler, John , Shoirah, Hazem , Tadi, Prasanna , Tememe, Danoushka, Totoraitis, Ruta, Walker, Greg , Ziayee, Habibullah, Caufield, Lori, Yeager, Carol, Forbes, Jennifer , Schwart, Karl Q., Knight, Peter A. , Ling, Frederick, Benesch, Curtis, Bogachan, Sahin, Hicks, George L., Kelly, Adam G. , Narins, Craig R. , Stuver, Thomas, Adams, Kathy, Blair-Anton, Lynn, Haynes, Mary Lou, Watts, Carol, Baker, Michael , Mendes, Lisa A., Kaiser, Clayton A., Robbins, Mark, Zhao, David , Ahmad, Rashid, Crenshaw, Marshall, Fredi, Joseph L., Hermann, Lisa, Hoff, Steven J. , Levack, Melissa M., Mittal, Shilpi , O’Duffy, Anne E, Petracek, Michael R., Baer, Judy, Liang, Grace , Nguyen, Son , Nguyen, Patricia K. , Burdon, Thomas A., Giacomini, John C., Yong, Celina M. , Buchbinder, Maurice , Fann, James I. , Kilgore, Shannon M., Mitchell, R. Scott, McDaniel, Sharon S., Pack, Angelina, White, Wendi, Young, Travis S. , Burgess, Pam, Pu, Min , Upadhya, Bharathi , Applegate, Robert J., Kon, Neal D., Arnan, Martinson, Baghshomali, Sanam, Bishop, L. R., Bradbury, Edward, Gandhi, Sanjay , Kincaid, Edward H., Lefkowitz, David , Lisle, Benjamin, Batteria, Melissa, Rerisi, Elizabeth, Stepinowski, Kimberly, Senicola, Tanya, Goncalves, John, Schubach, Scott , Schwartz, Richard, Antaky, Karin, Christiansen, C, Marzo, Kevin , Michel, Kathleen, Varghese, Princy , Wirkowski, Elizieta, Lévesque, Linda E. , Cleman, Michael , Forrest, John K. , Hashim, Sabet, Mangi, Abeel A. , Amin, Hardick, Darr, Umer, Dewar, Michael, Faheem, Osman, Geirsson, Arnar , Kaleel, Abdel Salam, Kaple, Ryan , Lansky, Alexandra, Grory, Brian Mac, Pfau, Steven , Schindler, Joseph , Yuh, David D., Serruys, Patrick W , Limaye, Kaustubh , Windecker, Stephan , Reardon, Michael J , Bode, Felix J , Mieghem, Nicolas M. Van , Søndergaard, Lars , Olsen, Peter Skov , Crestanello, Juan A. , George, Isaac , Serruys, Patrick W. , Williams, Mathew , Adams, David , Investigators, SURTAVI Trial, Meyer, Karen, Roberts, Dana, Sorajja, Paul , Flavin, Thomas, Gössl, Mario , Mooney, Michael R , Pendleton, Kristin, Fry, Robert, Heine, Carl, Tran, Tin, Bremer, Karen, Pieter, Jan, Verbiest, Henk, Waller, Deborah, Ahmed, Arshad , Allaqaband, Suhail Q. , Werner, Paul , Bessette, Lynn, Klein, Jason, Brady, Kevin, Chung, Steven, Franz, Douglas, Pershad, Ashish , Porter, Charlotte, Craig, John, Elijovich, Lucas , Wolf, Bradley, Wright, Lance, Roberts, Brad, Henry, Carl, Laham, Roger J. , Burke, David, Chui, Angus Shing Fung , Liu, David M. , Nathan, Senthil, Pinto, Duane S. , Searls, D. Eric, Fisher, Susan, Lim, D. Scott , Ng, Ken, Bates, Michael, Grey, William, Rose, Geoffrey, Scherer, Markus, Martin, Jerry, Cheng, Wen, Kar, Saibal , Mody, Cyrus, Ramzy, Danny , Sohn, Jeanie, Hahn, Rebecca T , Contreras, Jose Gutierrez, Kummer, Benjamin R. , Miller, Eliza C. , Nazif, Tamim , Qureshi, Abid, Rostanski, Sara , Willey, Joshua , Yaghi, Shadi , Rosenbloom, Michael, Schell, Wendy, Huang, Hong , Ali, Omar, Henry, Scott, Bleiziffer, Sabine , Hengstenberg, Christian , Brenner, Susanne, Kasel, Albert Markus , Kreuzpointner, Robert , Poppert, Holger , Seifert, Christian, Voß, Bernhard , Cowhig, Dahlia, Newbold, Stephanie, Velazquez, Eric J. , Harrison, J. Kevin, Hughes, George Chad , Ali, Yasmin, Gokhale, Sankalp , Hendry, Robert, Hernandez, Christian, Klein, Michael, Kolls, Brad J. , Maldonado, Andres M. Pineda, Price, Andrew James , Sherwood, Matthew W. , Swisher, Christa B. , Wang, Andrew , Lamm, Janet, Schroeder, Ryan, De, Ajanta, Charles, Elizabeth, Wheeler, Lauren, Merlino, John , Greene, James, Harrison, Amy, Leshnower, Bradley G. , Miller, Jeffrey S. , Nahab, Fadi B , Stewart, James, Kappetein, A. Pieter , Bekkers, Jos A. , Jaegere, Peter Paul de, Koudstaal, Peter J. , Henderson, Amy, Schneider, David J. , Tischler, Marc, Ittleman, Frank P., Coyle, David, Ehle, Gregory L., El-Haddad, Mohamed, Falduto, Catherine, Gorman, Mark, Seecheran, Naveen Anand , Burgess, Brian, Cummings, Christopher, Holland, Neil, Long, Doug, Barton, Sally, Mariscalco, Giovanni , Reid, Lori, Reilly, Susan, Seshiah, Puvi , Azemi, Talhat, Brown, Robert, Hammond, Jonathan , Underhill, David J., Escobar, Jose, Solanki, Ashish, Cooper, Raymond, Wang, Dee Dee , Greenbaum, Adam B. , Guerrero, Mayra , Cosme, Carlos De La Cruz, Muñoz-García, Antonio J. , Torres, Marta, Hera, Jesús M. de la , Tassa, Cesar Morís de la, Fernández, Pablo Avanzas, Fernández, Lorena Benavente, Valle, Raquel Del, Arnold, Marcel , Beyeler, Morin , Capek, Lukas, Corpataux, Noé , Göldlin, Martina B., Lanz, Jonas , Praz, Fabien , Spirito, Alessandro , Stortecky, Stefan , Allen, Meredith, Gonzales, Michael, Whisenant, Brian K. , Citro, Kathleen, Fisher, Michele, Shah, Ashish S. , Bui, Anh, Watanabe, Colin, Pfeffer, Thomas A , Bäck, Magnus , Rück, Andreas , Palma, Rodney De , Anderson, Michelle, Limaye, Sameer, Farhi, Anita, Ricketts, Melissa, Mandel, Steven, Chu, Michael , Bagur, Rodrigo , Gofton, Teneille , McKenzie, F. Neil, Mirsattari, Seyed M. , Young, Bryan, Dajani, Khaled Z. , Darki, Amir , Schwartz, Jeffrey, Howe-Clayton, Desirae L., Bruce, Charles J. , Freeman, William D. , Nkomo, Vuyisile T. , Pislaru, Sorin V. , Alkhouli, Mohamad , Maor, Elad , Panaich, Sidakpal , Peterson, Angela, Raphael, Claire E. , Sanon, Saurabh , Scharf, Eugene , Lapierre, Serge, Piazza, Nicolo, Rooij, Frank van, Barnes, Caroline, Griffin, Sandra, Goldstein, Steven A. , Marcus, Rachel, Widell, Jared K., Lowery, Robert, Klein, Marc, Jacoby, Michael, Purpura, Jenelle, Cohen, Barry, English, Karen, Généreux, Philippe , Slater, James N. , Turner, Joanne, Montgomery, Susan, Barry, Michael J. , Navas, Jorge, Patel, Vijay S , Arora, Ajay K., Stone, Lisa, Turner, Nancy, Singh, Julie, Chan, Grace, DeOrchis, Vincent S., Esposito, Rick, Han, Michael David , Kaplan, Barry, Palazzo, Robert, Wright, Paul, Houanche, Pascale, Morales, Vanessa, Taylor, Zachary, Sarić, Muhamed , Galloway, Aubrey C. , Attubato, Michael , Grossi, Eugene A. , Jones, Danielle, Orsinelli, David A. , Ryan, James Michael, Ryan, Thomas A. , Kılıç, Ahmet , O'Neil, Susan, Cheatham, John P. , Mehl, Brad, Ghani, Mohammad, Randolph, John F. , Williams, John Paul , Tucker, Claire, Dean, David A. , Gott, John, Russell, Christopher, Vannan, Mani A. , Butler, Kim, Spangler, Jessica, Maini, Brijeshwar , Mumtaz, Mubashir, Aneja, Parul, Shah, Jagdish, Gebhardt, Linda, Jones, Ursula, John, Henriette, Fuchs, Angela, Sedaghat, Alexander , Vasa‐Nicotera, Mariuca , Groth, Susanne, Kristensen, Line, Rosenberg, Tine , Møller, Jacob Eifer , Andersen, Henrik, Bieliauskas, Gintautas , Carranza, Christian Lildal , Backer, Ole De , Hansen, Klaus, Lund, Jens, Richards, David A. , Hicks, William, Hayes, Natalie, King, Dana, Chhatriwalla, Adnan K , Cohen, David Jonathan , Jensen, Ann, Bechis, Mary Z., Hu, Stephen, Tyner, Jeffrey W. , BREWSTER, SCOT A., Hanna, Nicholas, Patel, Aalok P. , Thompson, Caleb, Walsh, Joseph, Cohen, Daniel, Jordan, Grace, Helm, Elizabeth, Rai, Vivek, Liang, David H. , Miller, D. Craig , Yeung, Alan C. , Rost, Ilona, Heijmen, Robin H. , Ten Berg, Jurrien , Bosschaert, Mike A.R., Berke, Andrew, Reynolds, Rebecca M. , Sharma, Rakesh , Stuart, Amanda, Chandrasekaran, Venkatachalam, Herbert, Natalie, Batra, Sanjay, Cullis, Paul, Martin, James G. , Burkert, Mary Lynn, Wheatley, Jessica, Ball, Michael, Robison, Robert, Fremes, Stephen E. , Elbaz‐Greener, Gabby , Feld, Yair , Wijeysundera, Harindra C. , Beck, Pamela, Nelson, Ana, Malek, Ali R. , Pan, Hao , Ramos, Angelica, Brinkman, William T. , Gopal, Ambarish, Szerlip, Molly , Jacobs, Amber, Ludwig, Sheryl, Underwood, Carol, Faza, Nadeen Nader , Atkins, Marvin D. , Bledsoe, Don, Chiu, David, Goel, Sachin S. , Gray, Tiffany, Lin, Chun, White, Shannon, Wong, Richmond, Lau, Jeffrey, Nakamura, Dean, Gallagher, Lauren, Siki, Mary A. , Herrmann, Howard C. , Desai, Nimesh D. , Messé, Steven R. , Price, Raymond, Quinn, Colin, Vallabhajosyula, Prashanth , Wu, Libo, Horlick, Eric , Silver, Frank, Beyersdorf, Friedhelm , Neumann, Franz‐Josef , Siepe, Matthias , Thoma, Martin, Hager, Christine, Stader, Michael, Stämpfli, Simon F. , Falk, Volkmar , Maisano, Francesco , Holubec, Tomáš , Wegener, Susanne , Atkinson, Rachel, Costa, Marco , García, Carlos , Jadhav, Vikram, Le, Scott, Miller, Benjamin F. , Deo, Salil V. , Anderson, Jennifer , Page, Susie, Freeman, Jon, Alfonso, Carlos, Panos, Anthony L. , Romano, José G. , Adelman, Eric E. , Kim, Karen C. , McDermott, Margaret, Pace, Robert, Ramchandren, Sindhu , Wang, Michael, Zahuranec, Darin B. , Ruel, Marc , Glover, Chris, Cavalcante, João L. , Sultan, Ibrahim , Campbell, David, Giurgiutiu, Dan‐Victor , Gulati, Deepak, Hawkes, Christine, Henry, Lisa, Jadhav, Ashutosh P. , Klein, Bradley, Rangaraju, Srikant , Rocha, Marcelo, Streib, Christopher , Walker, Greg, Ball, Stephen, Goel, Kashish , Ahmad, Rashid, Hermann, Lisa, Hoff, Steven, Kirshner, Howard S. , Baer, Judy, Liang, Grace, Heidenreich, Paul A. , McDaniel, Sharon, Young, Travis, Burgess, Pam, Pu, Min, Bishop, Laura, Gandhi, Sanjay, Lefkowitz, David, Rerisi, Elizabeth , Christiansen, Colleen, Misra, Ajay, Varghese, Princy, Levesque, Linda, Sugeng, Lissa , Dewar, Michael, Greer, David M. , Grory, Brian Mac, Thompson, Craig, Youn, Teddy, Yun, James J

Mayo Clinic

JAMA Cardiology | August 24, 2022 | Volume: 7 | Issue: 10 | Pages: 1000

10.1001/jamacardio.2022.2695 | PMID 36001335 Get It

Importance In patients with severe aortic valve stenosis at intermediate surgical risk, transcatheter aortic valve replacement (TAVR) with a self-expanding supra-annular valve was noninferior to surgery for all-cause mortality or disabling stroke at 2 years. Comparisons of longer-term clinical and hemodynamic outcomes in these patients are limited. Objective To report prespecified secondary 5-year outcomes from the Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI) randomized clinical trial. Design, Setting, and Participants SURTAVI is a prospective randomized, unblinded clinical trial. Randomization was stratified by investigational site and need for revascularization determined by the local heart teams. Patients with severe aortic valve stenosis deemed to be at intermediate risk of 30-day surgical mortality were enrolled at 87 centers from June 19, 2012, to June 30, 2016, in Europe and North America. Analysis took place between August and October 2021. Intervention Patients were randomized to TAVR with a self-expanding, supra-annular transcatheter or a surgical bioprosthesis. Main Outcomes and Measures The prespecified secondary end points of death or disabling stroke and other adverse events and hemodynamic findings at 5 years. An independent clinical event committee adjudicated all serious adverse events and an independent echocardiographic core laboratory evaluated all echocardiograms at 5 years. Results A total of 1660 individuals underwent an attempted TAVR (n = 864) or surgical (n = 796) procedure. The mean (SD) age was 79.8 (6.2) years, 724 (43.6%) were female, and the mean (SD) Society of Thoracic Surgery Predicted Risk of Mortality score was 4.5% (1.6%). At 5 years, the rates of death or disabling stroke were similar (TAVR, 31.3% vs surgery, 30.8%; hazard ratio, 1.02 [95% CI, 0.85-1.22]; P = .85). Transprosthetic gradients remained lower (mean [SD], 8.6 [5.5] mm Hg vs 11.2 [6.0] mm Hg; P < .001) and aortic valve areas were higher (mean [SD], 2.2 [0.7] cm 2 vs 1.8 [0.6] cm 2 ; P < .001) with TAVR vs surgery. More patients had moderate/severe paravalvular leak with TAVR than surgery (11 [3.0%] vs 2 [0.7%]; risk difference, 2.37% [95% CI, 0.17%- 4.85%]; P = .05). New pacemaker implantation rates were higher for TAVR than surgery at 5 years (289 [39.1%] vs 94 [15.1%]; hazard ratio, 3.30 [95% CI, 2.61-4.17]; log-rank P < .001), as were valve reintervention rates (27 [3.5%] vs 11 [1.9%]; hazard ratio, 2.21 [95% CI, 1.10-4.45]; log-rank P = .02), although between 2 and 5 years only 6 patients who underwent TAVR and 7 who underwent surgery required a reintervention. Conclusions and Relevance Among intermediate-risk patients with symptomatic severe aortic stenosis, major clinical outcomes at 5 years were similar for TAVR and surgery. TAVR was associated with superior hemodynamic valve performance but also with more paravalvular leak and valve reinterventions.
AUGMENT: A Phase III Randomized Study of Lenalidomide Plus Rituximab (R2) Vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Leonard, John P. , Fowler, Nathan , Hong, Xiaonan, Zhang, Huilai , Offner, Fritz , Scheliga, Adriana , Nowakowski, Grzegorz S. , Fogliatto, Laura Maria , Moreira, Cláudia, Kalambakas, Stacey, Wu, Chengqing , Trněný, Marek , Izutsu, Koji , Zhu, Jun , Pinto, Antonio , Re, Francesca, Scheinberg, Phillip , Flinn, Ian W. , Liu, David , Fustier, Pierre , Gribben, John G.

Mayo Clinic

Blood | October 14, 2019 | Volume: 132 | Issue: Supplement 1 | Pages: 445-445

10.1182/blood-2018-99-110861 Get It

Abstract Background: Indolent non-Hodgkin lymphoma (iNHL), including follicular lymphoma (FL) and marginal zone lymphoma (MZL), is typically responsive to initial chemoimmunotherapy, but relapse is expected. Single-agent rituximab is FDA approved and frequently administered for patients with relapsed/refractory (R/R) low-grade or follicular CD20-positive B-cell NHL. Lenalidomide is an immunomodulatory agent with preclinical and clinical antilymphoma activity alone and in combination with rituximab. We compared the efficacy and safety of lenalidomide plus rituximab (R2) to rituximab (plus placebo) in patients with R/R iNHL. Methods: AUGMENT (NCT01938001) is a multicenter, double-blind, randomized phase III study of R2 vs rituximab/placebo (control) in patients with FL grade 1-3a or MZL who were previously treated with ≥ 1 prior systemic therapy with documented relapsed or refractory disease but not refractory to rituximab (refractory was defined as < partial response to rituximab or rituximab-chemotherapy OR disease progression < 6 months after last rituximab dose). Patients were stratified by prior rituximab treatment (yes vs no), time since last antilymphoma therapy (≤ 2 vs > 2 years), and histology (FL vs MZL), and then randomized 1:1 to R2 or control for up to 1 year. R2 patients received oral lenalidomide 20 mg/day (d), d1-21/28 for 12 cycles plus rituximab IV 375 mg/m2 weekly in cycle 1 and d1 of cycles 2-5. Control patients received rituximab and placebo on the same schedule. Dose modifications were pre-specified in the protocol to manage toxicities. The primary endpoint was progression-free survival (PFS) per 2007 IWG criteria without PET as assessed by Independent Review Committee (IRC; central review). Secondary endpoints included overall response rate (ORR), complete response (CR), duration of response (DOR), time-to-next antilymphoma treatment (TTNLT), overall survival (OS), and safety. Results: A total of 358 patients were randomized (n = 178 R2; n = 180 control), median age was 63 years (range, 26 - 88), 34% FLIPI score ≥ 3, and histologies of 82% FL/18% MZL. Median number of prior systemic treatments was 1 (range, 1 - 12); 84% received prior rituximab and 51% had prior antilymphoma therapy within 2 years of enrollment. At median follow-up of 28.3 months, the study met its primary endpoint of PFS with HR = 0.46 (95% CI, 0.34 - 0.62; P < 0.0001) (Figure 1). Median PFS was 39.4 months for R2 vs 14.1 months for control. IRC-assessed ORR for R2 was 78% vs 53% for control (P < 0.0001). CR was 34% for R2 vs 18% for control (P = 0.001). Median DOR was 36.6 and 21.7 months for R2 and control arms, respectively. TTNLT was improved for R2 vs control with HR = 0.54 (95% CI, 0.38 - 0.78; P = 0.0007). OS data were not mature with 16 deaths reported in the R2 arm vs 26 deaths in control (HR = 0.61 [95% CI, 0.33 - 1.13]). Selected all-grade treatment-emergent adverse events (TEAEs) of interest more common in the R2 vs control arm (≥ 10% difference) were infections (63% vs 49%), cutaneous reactions (32% vs 12%), constipation (26% vs 14%), thrombocytopenia (15% vs 4%), and tumor flare reaction (11% vs 1%). Grade 3/4 TEAEs were reported in 69% R2 and 32% control patients. More frequent grade 3/4 TEAEs in the R2 vs control arm were primarily attributable to increased neutropenia (50% vs 13%) and leukopenia (7% vs 2%). Grade 5 TEAEs were reported in 2 patients in each arm. TEAEs leading to discontinuation of lenalidomide occurred in 9% of patients vs 5% for rituximab + placebo. Neutropenia was the only TEAE leading to discontinuation of lenalidomide in > 1 patient (n = 5). Seventy-one percent of R2 patients completed all 12 cycles of planned treatment vs 61% of control. Disease progression was the leading reason for discontinuation of lenalidomide/placebo (n = 21 R2, n = 54 control). Conclusions: R2 demonstrated superior efficacy over rituximab monotherapy (plus placebo) as measured by the primary endpoint of progression-free survival as well as secondary endpoints of ORR, CR, DOR, and TTNLT in patients with R/R FL grade 1-3a and MZL. At this early analysis, fewer deaths have been observed in the R2 arm. Despite additional hematologic toxicity, greater efficacy of the R2 regimen (and fewer early progressions) allowed more patients to complete the planned therapy and delayed the need for subsequent treatment. R2 represents an important new treatment option in patients with previously treated FL/MZL, with meaningful advantages over single-agent rituximab. Disclosures Leonard: Celgene: Consultancy; Karyopharm: Consultancy; ADC Therapeutics: Consultancy; MEI Pharma: Consultancy; Juno: Consultancy; Bayer: Consultancy; AstraZeneca: Consultancy; Sutro: Consultancy; Biotest: Consultancy; United Therapeutics: Consultancy; Pfizer: Consultancy; Novartis: Consultancy; Genentech/Roche: Consultancy; Gilead: Consultancy; BMS: Consultancy. Trněný:F. Hoffman-La Roche Ltd: Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Advisory board, Research Funding; Incyte: Membership on an entity's Board of Directors or advisory committees, Other: Advisory board; Celgene: Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Advisory board; Abbvie: Honoraria, Research Funding; Gilead: Honoraria; Janssen: Membership on an entity's Board of Directors or advisory committees, Other: Advisory board; Takeda: Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Advisory board; Morphosys: Membership on an entity's Board of Directors or advisory committees, Other: Advisory board; Sandoz: Honoraria. Izutsu:Otsuka: Honoraria; Bristol- Myers Squibb: Honoraria; Nihon Medi-Physics: Honoraria; Novartis: Honoraria; Mundhi: Honoraria; HUYA Bioscience International: Research Funding; Kyowa Hakko Kirin: Honoraria; Takeda: Honoraria, Research Funding; Abbvie: Honoraria, Research Funding; Amgen: Research Funding; Bayer: Consultancy, Honoraria, Research Funding; Gilead Sciences: Honoraria; Eisai: Honoraria, Research Funding; Chugai: Honoraria, Research Funding; Daiichi Sankyo: Honoraria, Research Funding; Astellas: Honoraria, Research Funding; Janssen: Honoraria, Research Funding; Zenyaku: Research Funding; Celltrion: Research Funding; MSD: Honoraria; Ono: Honoraria, Research Funding; Symbio: Research Funding; Celgene: Consultancy, Research Funding; Solasia: Research Funding; Sanofi: Research Funding; Meiji Seika: Honoraria; Shionogi: Honoraria; Asahi Kasei: Honoraria. Fowler:Janssen: Consultancy, Research Funding; Pharmacyclics: Consultancy, Research Funding. Zhu:Beijing Cancer Hospital (Peking University Cancer Hospital): Employment. Scheliga:INCA - Instituto Nacional Do Cancer, Brazil: Employment. Pinto:Servier: Consultancy; BMS: Honoraria, Research Funding; MSD: Honoraria; Roche: Honoraria; Takeda: Honoraria; Celgene: Honoraria; Gilead: Honoraria. Scheinberg:Novartis: Consultancy, Speakers Bureau; Janssen: Honoraria, Research Funding; Pfizer: Speakers Bureau. Flinn:Trillium: Research Funding; Takeda: Research Funding; Calithera: Research Funding; Incyte: Research Funding; Verastem: Research Funding; ArQule: Research Funding; Janssen: Research Funding; Pharmacyclics: Research Funding; Seattle Genetics: Research Funding; Forty Seven: Research Funding; Agios: Research Funding; BeiGene: Research Funding; Kite: Research Funding; Portola: Research Funding; Verastem: Consultancy, Research Funding; Celgene: Research Funding; Pfizer: Research Funding; Forma: Research Funding; Merck: Research Funding; Novartis: Research Funding; Constellation: Research Funding; Curis: Research Funding; Infinity: Research Funding; TG Therapeutics: Research Funding; Genentech: Research Funding; Gilead: Research Funding. Moreira:Instituto Português de Oncologia do Porto FG, EPE, Porto, Portugal: Employment. Liu:Celgene: Employment, Equity Ownership. Kalambakas:Celgene: Employment, Equity Ownership. Fustier:Celgene: Employment, Equity Ownership. Wu:Celgene: Employment, Equity Ownership. Gribben:Cancer Research UK: Research Funding; Unum: Equity Ownership; Novartis: Honoraria; Abbvie: Honoraria; Wellcome Trust: Research Funding; Acerta Pharma: Honoraria, Research Funding; Kite: Honoraria; NIH: Research Funding; Roche: Honoraria; Janssen: Honoraria, Research Funding; Medical Research Council: Research Funding; Celgene: Consultancy, Honoraria, Research Funding; TG Therapeutics: Honoraria; Pharmacyclics: Honoraria.
Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia
Bustoros, Mark , Sklavenitis‐Pistofidis, Romanos , Kapoor, Prashant , Kastritis, Efstathios , Zanwar, Saurabh , Fell, Geoffrey, Abeykoon, Jithma P. , Hornburg, Kalvis , Neuse, Carl Jannes , Liu, David , Soiffer, Jenny , Gavriatopoulou, Maria , Boehner, Cody J. , Cappuccio, Joseph M. , Dumke, Henry, Reyes, Kaitlen, Soiffer, Robert J. , Kyle, Robert A. , Ansell, Stephen M. , Trippa, Lorenzo , Ghobrial, Irene M. , Kastritis, Efstathios , Ghobrial, Irene M , Sklavenitis-Pistofidis, Romanos , Liu, Chia‐Jen , Fell, Geoffrey G. , Marinac, Catherine R. , Treon, Steven P. , Castillo, Jorge J. , Dimopoulos, Meletios Α.

Mayo Clinic

Journal of Clinical Oncology | April 16, 2019 | Volume: 37 | Issue: 16 | Pages: 1403-1411

10.1200/jco.19.00394 | PMID 30990729 Get It

BACKGROUND Waldenström macroglobulinemia (WM) is preceded by asymptomatic WM (AWM), for which the risk of progression to overt disease is not well defined. METHODS We studied 439 patients with AWM, who were diagnosed and observed at Dana-Farber Cancer Institute between 1992 and 2014. RESULTS During the 23-year study period, with a median follow-up of 7.8 years, 317 patients progressed to symptomatic WM (72%). Immunoglobulin M 4,500 mg/dL or greater, bone marrow lymphoplasmacytic infiltration 70% or greater, β2-microglobulin 4.0 mg/dL or greater, and albumin 3.5 g/dL or less were all identified as independent predictors of disease progression. To assess progression risk in patients with AWM, we trained and cross-validated a proportional hazards model using bone marrow infiltration, immunoglobulin M, albumin, and beta-2 microglobulin values as continuous measures. The model divided the cohort into three distinct risk groups: a high-risk group with a median time to progression (TTP) of 1.8 years, an intermediate-risk group with a median TTP of 4.8 years, and a low-risk group with a median TTP of 9.3 years. We validated this model in two external cohorts, demonstrating robustness and generalizability. For clinical applicability, we made the model available as a Web page application ( www.awmrisk.com ). By combining two cohorts, we were powered to identify wild type MYD88 as an independent predictor of progression (hazard ratio, 2.7). CONCLUSION This classification system is positioned to inform patient monitoring and care and, for the first time to our knowledge, to identify patients with high-risk AWM who may need closer follow-up or benefit from early intervention.
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma
Leonard, John P. , Izutsu, Koji , Fowler, Nathan , Hong, Xiaonan, Zhu, Jun , Zhang, Huilai , Offner, Fritz , Scheliga, Adriana , Nowakowski, Grzegorz S. , Pinto, Antonio , Fogliatto, Laura Maria , Moreira, Cláudia, Cabeçadas, José , Kalambakas, Stacey, Fustier, Pierre , Wu, Chengqing , Investigators, for the AUGMENT Trial, Izutsu, Koji , Trněný, Marek , Re, Francesca, Scheinberg, Phillip , Flinn, Ian W. , Liu, David , Gribben, John G. , Investigators, for the AUGMENT Trial, Pinto, Antonio

Mayo Clinic

Journal of Clinical Oncology | March 21, 2019 | Volume: 37 | Issue: 14 | Pages: 1188-1199

10.1200/jco.19.00010 | PMID 30897038 Get It

PURPOSEPatients with indolent non-Hodgkin lymphoma typically respond well to first-line immunochemotherapy. At relapse, single-agent rituximab is commonly administered. Data suggest the immunomodulatory agent lenalidomide could increase the activity of rituximab.METHODSA phase III, multicenter, randomized trial of lenalidomide plus rituximab versus placebo plus rituximab was conducted in patients with relapsed and/or refractory follicular or marginal zone lymphoma. Patients received lenalidomide or placebo for 12 cycles plus rituximab once per week for 4 weeks in cycle 1 and day 1 of cycles 2 through 5. The primary end point was progression-free survival per independent radiology review.RESULTSA total of 358 patients were randomly assigned to lenalidomide plus rituximab (n = 178) or placebo plus rituximab (n = 180). Infections (63% v 49%), neutropenia (58% v 23%), and cutaneous reactions (32% v 12%) were more common with lenalidomide plus rituximab. Grade 3 or 4 neutropenia (50% v 13%) and leukopenia (7% v 2%) were higher with lenalidomide plus rituximab; no other grade 3 or 4 adverse event differed by 5% or more between groups. Progression-free survival was significantly improved for lenalidomide plus rituximab versus placebo plus rituximab, with a hazard ratio of 0.46 (95% CI, 0.34 to 0.62; P < .001) and median duration of 39.4 months (95% CI, 22.9 months to not reached) versus 14.1 months (95% CI, 11.4 to 16.7 months), respectively.CONCLUSIONLenalidomide improved efficacy of rituximab in patients with recurrent indolent lymphoma, with an acceptable safety profile.
Characterization of immune-related adverse events (irAEs) in a phase 3 trial of ipilimumab (Ipi) versus placebo (Pbo) in post-docetaxel mCRPC.
Gerritsen, Winald R. , Kwon, Eugene D., Scher, Howard I. , Bossi, Alberto, Eertwegh, Alfons J. van den, Drake, Charles G. , McHenry, Brent, Fizazi, Karim , Beer, Tomasz M. , Logothetis, Christopher J. , Liu, David

Mayo Clinic

Journal of Clinical Oncology | February 24, 2017 | Volume: 32 | Issue: 4_suppl | Pages: 52-52

10.1200/jco.2014.32.4_suppl.52 Get It

52 Background: Ipi enhances antitumor immunity by blocking cytotoxic T-lymphocyte antigen-4. We recently reported the results of CA184-043, a phase 3 study of post-docetaxel mCRPC with Ipi vs Pbo, following single-dose radiotherapy (RT). While the study did not meet the primary endpoint of improving overall survival (HR=0.85, p=0.053), Ipi demonstrated antitumor activity in other efficacy endpoints, including progression-free survival. The present analyses further characterize the safety profile of Ipi in this study. Methods: Safety was evaluated for all treated patients (pts; N=393 for Ipi 10 mg/kg, N=396 for Pbo) starting from first study dose and ending 70 days after the last study dose, including maintenance dosing. Results: Any grade (Gr) irAEs occurred in 63.4% and 21.7% of pts in the Ipi and Pbo arms, respectively. Most common Gr 3/4 irAEs were gastrointestinal (GI) (18.1%; mostly diarrhea and colitis). Gr 3/4 liver irAEs (4.6%) were mostly elevations in AST or ALT. Other Gr 3/4 irAEs were uncommon: endocrine (2.0%), skin (1.0%), and neurological (0.3%). Among Ipi-treated pts, there were no meaningful differences in the frequency or severity of GI AEs between those who received baseline pelvic RT and those who did not (n=141 vs 252; any Gr 77.3% vs 69.8%; Gr 3/4 25.5% vs 21.8%, respectively). There were 5 GI perforations in the Ipi arm (3 within 70 days of last dose [2 related, 1 unrelated], 2 after 70 days of last dose, both related), and none in the Pbo arm. Deaths due to study drug toxicity, as per the investigators, occurred in 4 pts (4, Ipi and 0, Pbo). Conclusions: In this study of Ipi in mCRPC, the most frequent severe irAEs were diarrhea and colitis. Most irAEs were manageable using established treatment algorithms. Clinical trial information: NCT00861614. [Table: see text]
Results of subset analyses on overall survival (OS) from study CA184-043: Ipilimumab (Ipi) versus placebo (Pbo) in post-docetaxel metastatic castration-resistant prostate cancer (mCRPC).
Drake, Charles G. , Kwon, Eugene D., Fizazi, Karim , Bossi, Alberto , Eertwegh, Alfons J. van den, Scher, Howard I. , McHenry, Brent, Gerritsen, Winald R., Logothetis, Christopher J. , Beer, Tomasz M. , Liu, David M.

Mayo Clinic

Journal of Clinical Oncology | February 24, 2017 | Volume: 32 | Issue: 4_suppl | Pages: 2-2

10.1200/jco.2014.32.4_suppl.2 Get It

2 Background: The CA184-043 phase 3 study did not reach statistical significance for its primary endpoint of OS (HR=0.85, p=0.053). However, antitumor activity was observed in other efficacy endpoints, including progression-free survival. Prespecified subset analyses were performed to understand if any prognostic features may identify mCRPC patients (pts) more likely to benefit from Ipi treatment. Methods: 799 pts were randomized to receive a single dose of radiotherapy (RT) followed by either Ipi (N=399) or Pbo (N=400). Prespecified subset analyses based on Kaplan-Meier/Cox methodology were performed using known prognostic factors for OS in mCRPC. Results: Prespecified subset analyses suggested that Ipi may be more active in pts with favorable prognostic factors, including no visceral disease, alkaline phosphatase <1.5 ULN, and hemoglobin ≥11 g/dL (Table). The safety profile in this study was consistent with previous reports of Ipi. Conclusions: Based on these subset analyses, Ipi added to RT appears to have greater activity than RT alone in pts with a favorable prognostic profile. These results support continued investigation of Ipi in the ongoing CA184-095 study in chemotherapy-naive mCRPC pts. Clinical trial information: NCT00861614. [Table: see text]